BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15265876)

  • 1. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses.
    Kanaoka Y; Boyce JA
    J Immunol; 2004 Aug; 173(3):1503-10. PubMed ID: 15265876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional aspects of human cysteinyl leukotriene receptors.
    Capra V
    Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
    Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends.
    Capra V; Thompson MD; Sala A; Cole DE; Folco G; Rovati GE
    Med Res Rev; 2007 Jul; 27(4):469-527. PubMed ID: 16894531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.
    Jiang Y; Borrelli LA; Kanaoka Y; Bacskai BJ; Boyce JA
    Blood; 2007 Nov; 110(9):3263-70. PubMed ID: 17693579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice.
    Beller TC; Maekawa A; Friend DS; Austen KF; Kanaoka Y
    J Biol Chem; 2004 Oct; 279(44):46129-34. PubMed ID: 15328359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
    Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
    Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.
    Beller TC; Friend DS; Maekawa A; Lam BK; Austen KF; Kanaoka Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3047-52. PubMed ID: 14970333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteinyl leukotriene receptors.
    Hui Y; Funk CD
    Biochem Pharmacol; 2002 Dec; 64(11):1549-57. PubMed ID: 12429344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure.
    Woszczek G; Pawliczak R; Qi HY; Nagineni S; Alsaaty S; Logun C; Shelhamer JH
    J Immunol; 2005 Oct; 175(8):5152-9. PubMed ID: 16210619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
    Barrett NA; Fernandez JM; Maekawa A; Xing W; Li L; Parsons MW; Austen KF; Kanaoka Y
    J Immunol; 2012 Nov; 189(9):4556-65. PubMed ID: 23002438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotriene receptors, old and new; implications for asthma.
    Laidlaw TM; Boyce JA
    Clin Exp Allergy; 2012 Sep; 42(9):1313-20. PubMed ID: 22925317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
    Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
    Maekawa A; Kanaoka Y; Lam BK; Austen KF
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway.
    Ciccarelli R; D'Alimonte I; Santavenere C; D'Auro M; Ballerini P; Nargi E; Buccella S; Nicosia S; Folco G; Caciagli F; Di Iorio P
    Eur J Neurosci; 2004 Sep; 20(6):1514-24. PubMed ID: 15355318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
    Maekawa A; Kanaoka Y; Xing W; Austen KF
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.